Core Points - The company, Hema Medical (03309.HK), announced a share buyback of 200,000 shares for a total cost of HKD 342,400 on November 24, 2025 [1] - As of the market close on November 24, 2025, Hema Medical's stock price was HKD 1.71, reflecting a decline of 1.16% with a trading volume of 682,000 shares and a turnover of HKD 1.168 million [1] - The stock has not received any ratings from investment banks in the past 90 days, indicating low analyst coverage [1] Company Performance Metrics - Hema Medical's market capitalization is HKD 2.143 billion, ranking 15th in the medical services sector [1] - Key performance indicators compared to the industry average: - Return on Equity (ROE): -6.36% vs. 0.02% (ranked 39th) [1] - Market capitalization: HKD 2.143 billion vs. HKD 7.725 billion (ranked 15th) [1] - Revenue: HKD 1.935 billion vs. HKD 3.832 billion (ranked 15th) [1] - Net Profit Margin: 5.95% vs. -843.36% (ranked 25th) [1] - Gross Profit Margin: 31.12% vs. 39.76% (ranked 28th) [1] - Debt Ratio: 29.8% vs. 74.15% (ranked 21st) [1]
希玛医疗(03309.HK)发布公告，于2025年11月24日，该公司斥资34.24万港元回购20万股